Jonathan Holbrook
YOU?
Author Swipe
View article: Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial Open
View article: Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease
Constipation Is Linked to Neuroinflammation in Early Parkinson's Disease Open
Background Constipation is a risk factor for the onset and accelerated progression of Parkinson's disease (PD), but the mechanisms underlying this association are unknown. Neuroinflammation in PD has been demonstrated in postmortem and neu…
View article: Efficacy and potential human and economic impact of a broadly protective betacoronavirus vaccine
Efficacy and potential human and economic impact of a broadly protective betacoronavirus vaccine Open
Within two decades, three different betacoronaviruses (β-CoV) have spilled over from animals to humans causing high consequence diseases, the most recent causing the COVID-19 pandemic. Using computational antigen design technology, we deve…
View article: Peripheral-central immune crosstalk in Parkinson’s disease and its association with clinical severity
Peripheral-central immune crosstalk in Parkinson’s disease and its association with clinical severity Open
This exploratory study suggests that peripheral and central immune changes are closely linked in PD, and relevant to clinical disease severity. These findings warrant further validation and exploration to identify immune biomarkers linked …
View article: A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
A 14‐Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's Open
There is a pressing need for blood biomarkers that can identify Huntington's disease (HD) gene carriers' proximity to manifest disease. We previously examined serial serum neurofilament light (NfL) concentrations in 21 premanifest HD gene …
View article: Covering All Bases: A Computational Method to Design Broad-spectrum T-cell-inducing Vaccines Applied to <i>Betacoronaviruses</i>
Covering All Bases: A Computational Method to Design Broad-spectrum T-cell-inducing Vaccines Applied to <i>Betacoronaviruses</i> Open
Antigenically diverse pathogens, such as coronaviruses, pose substantial threats to global health. This highlights the need for effective broad-spectrum vaccines that elicit robust immune responses in a large proportion of the human popula…
View article: Natural killer cells have an activated profile in early Parkinson's disease
Natural killer cells have an activated profile in early Parkinson's disease Open
Immune dysregulation is heavily implicated in Parkinson's disease (PD) but the role of Natural Killer (NK) cells has not been well characterised. Accumulating evidence indicates the immune response peaks early in the disease, hence this st…
View article: Neurodegenerative Disease and the NLRP3 Inflammasome
Neurodegenerative Disease and the NLRP3 Inflammasome Open
The prevalence of neurodegenerative disease has increased significantly in recent years, and with a rapidly aging global population, this trend is expected to continue. These diseases are characterised by a progressive neuronal loss in the…
View article: Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease
Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery Disease Open
View article: WS12.6 Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
WS12.6 Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis Open
View article: Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations Open
View article: Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis Open
Previously, we showed that serum and monocytes from patients with CF exhibit an enhanced NLRP3-inflammasome signature with increased IL-18, IL-1β, caspase-1 activity and ASC speck release (Scambler et al. eLife 2019). Here we show that CFT…
View article: Author response: Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
Author response: Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis Open
View article: ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis Open
Cystic Fibrosis (CF) is a monogenic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, resulting in defective CFTR-mediated chloride and bicarbonate transport, with dysregulation of epitheli…
View article: Author response: ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis
Author response: ENaC-mediated sodium influx exacerbates NLRP3-dependent inflammation in cystic fibrosis Open
Article Figures and data Abstract Introduction Results Discussion Materials and methods Data availability References Decision letter Author response Article and author information Metrics Abstract Cystic Fibrosis (CF) is a monogenic diseas…
View article: Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation
Metabolic Reprograming of Cystic Fibrosis Macrophages via the IRE1α Arm of the Unfolded Protein Response Results in Exacerbated Inflammation Open
Cystic Fibrosis (CF) is a recessive genetic disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR mutations cause dysregulation of channel function with intracellular accumulation of misfolded…
View article: Tumour necrosis factor signalling in health and disease
Tumour necrosis factor signalling in health and disease Open
The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation…
View article: Excessive ENaC-mediated sodium influx drives NLRP3 inflammasome-dependent autoinflammation in cystic fibrosis
Excessive ENaC-mediated sodium influx drives NLRP3 inflammasome-dependent autoinflammation in cystic fibrosis Open
Cystic Fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and results in defective CFTR-mediated chloride transport, dysregulation of epithelial sodium channels (ENaC) and exaggerate…
View article: The effect of cysteamine and epigallocatechin gallate on the inflammatory phenotype in cystic fibrosis
The effect of cysteamine and epigallocatechin gallate on the inflammatory phenotype in cystic fibrosis Open
View article: EPS1.06 Overproduction of IL-6 and TNF through IRE1α is CFTR genotype dependent
EPS1.06 Overproduction of IL-6 and TNF through IRE1α is CFTR genotype dependent Open
View article: WS04.3 Sodium influx modulates innate immune inflammation and metabolism in cystic fibrosis
WS04.3 Sodium influx modulates innate immune inflammation and metabolism in cystic fibrosis Open
View article: WS04.5 The effect of cysteamine and epigallocatechin gallate on hyperresponsive inflammation in cystic fibrosis
WS04.5 The effect of cysteamine and epigallocatechin gallate on hyperresponsive inflammation in cystic fibrosis Open
View article: Autoinflammatory disease in the lung
Autoinflammatory disease in the lung Open
Summary Ascertaining the dominant cell type driving an immunological disease is essential to understanding the causal pathology and, therefore, selecting or developing an effective treatment. Classifying immunological diseases in this way …